Dean J. Naylor
Corporate Officer/Principal en The University of Queensland .
Cargos activos de Dean J. Naylor
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The University of Queensland | Corporate Officer/Principal | - | - |
Historial de carrera de Dean J. Naylor
Antiguos cargos conocidos de Dean J. Naylor.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Adelaide | Corporate Officer/Principal | - | - |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Australia | 4 |
Operativa
| Corporate Officer/Principal | 3 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Dean J. Naylor
- Experiencia
